paroxetine has been researched along with sertraline in 404 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 116 (28.71) | 18.2507 |
| 2000's | 151 (37.38) | 29.6817 |
| 2010's | 104 (25.74) | 24.3611 |
| 2020's | 33 (8.17) | 2.80 |
| Authors | Studies |
|---|---|
| Carlier, PR; Lo, MM; Lo, PC; Reynolds, IJ; Richelson, E; Sharma, TA; Tatsumi, M | 1 |
| Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Buck, LB; Petrascheck, M; Ye, X | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Jung, ME; Kang, SY; Kim, HJ; Kim, J; Kim, MJ; Kim, MS; Lee, J; Lee, KN; Lee, M; Lee, SH; Park, EJ; Park, WK; Seo, HJ; Son, EJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fry, EE; Ren, J; Stuart, DI; Zhao, Y | 1 |
| Alonso, C; Campillo, NE; Cuesta-Geijo, MÁ; Delgado, R; Gil, C; Ginex, T; Morales-Tenorio, M; Muñoz-Fontela, C | 1 |
| Chen, W; Han, S; Hu, Y; Li, H; Tong, X; Yang, L; Zuo, J | 1 |
| Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR | 1 |
| Grimsley, SR; Jann, MW | 1 |
| DeVane, CL | 1 |
| Johnson, AM; Tulloch, IF | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Koe, BK; Lebel, LA; Welch, WM | 1 |
| Rickels, K; Schweizer, E | 1 |
| Rothschild, AJ | 1 |
| Baumann, P; Rochat, B | 1 |
| Preskorn, SH | 4 |
| Anelli, M; Caccia, S; Codegoni, AM; Fracasso, C; Garattini, S | 1 |
| Finley, PR | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Frost, L; Lal, S | 1 |
| Jaffe, IA | 1 |
| Althof, SE | 1 |
| Helmeste, DM; Reist, C; Tang, SW; Vu, R | 1 |
| Barrett, J | 1 |
| Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF | 1 |
| Preskorn, S | 1 |
| Domino, EF; Holmes, RD; Lee, A; Markel, H | 1 |
| Deltito, JA | 1 |
| Cline, EJ; Kim, S; Kuhar, MJ; Scheffel, U | 1 |
| Iacono, RP; Toyama, SC | 1 |
| Bergeron, R; De Montigny, C; Debonnel, G | 1 |
| Kupfer, DJ | 1 |
| LaBranche, S | 1 |
| Hsu, JH; Shen, WW | 1 |
| Burke, MJ; Harvey, AT; Preskorn, SH | 1 |
| Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT | 1 |
| Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Volpicelli, SA | 1 |
| Newhouse, PA | 1 |
| Gammon, GD | 1 |
| Lazowick, AL; Levin, GM | 1 |
| García-Rodríguez, JA; Muñoz-Bellido, JL; Muñoz-Criado, S | 2 |
| Balon, R | 1 |
| Knowles, SR; Liu, BA; Mittmann, N; Shear, NH | 1 |
| Fava, GA; Grandi, S | 1 |
| Lesaca, TG | 1 |
| Reynolds, CF | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Harvey, AT; Preskorn, SH | 1 |
| Bell, CJ; Coupland, NJ; Potokar, JP | 1 |
| Bryant, SG | 1 |
| Cowen, PJ; McTavish, SF; Williamson, DJ | 1 |
| Leo, RJ | 1 |
| Harnett-Sheehan, K; Sheehan, DV | 1 |
| de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR | 1 |
| Kurz, X; Ottervanger, JP; Roisin, T; Stricker, BH; Van Ermen, AM | 1 |
| Franchini, L; Gasperini, M; Perez, J; Smeraldi, E; Zanardi, R | 1 |
| Baumann, P; Eap, CB | 1 |
| MacKay, AV; Price, JS; Waller, PC; Wood, SM | 1 |
| Rifkin, A | 1 |
| Meier, E; Sánchez, C | 1 |
| Charness, WE; Ferrando, SJ; Goldman, JD | 1 |
| Earley, B; Faherty, CJ; Leonard, BE | 1 |
| Devine, CL; Markowitz, JS | 1 |
| DePalma, RL; Katholi, CR; Modell, JD; Modell, JG | 1 |
| Darby, AL; Lesser, IM; Miller, BL; Swartz, JR | 1 |
| Constantino, JN; Kincaid, M; Liberman, M | 1 |
| Burke, WJ; Dewan, V; Folks, DG; Nadolny, GC; Roccaforte, WH; Wengel, SP | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Di Mascio, M; Esposito, E | 1 |
| Alderman, J; Allison, J; Chung, M; Greenblatt, DJ; Harrison, W; Penenberg, D; Preskorn, SH | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Bousoño, M; Calcedo, A; Carrasco, JL; Ciudad, J; Daniel, E; De la Gandara, J; Derecho, J; Franco, M; Gomez, MJ; Izquierdo, JA; Ledesma, A; Llorca, G; Macias, JA; Martin, T; Montejo-González, AL; Perez, V; Sanchez, JM; Sanchez, S; Vicens, E | 1 |
| Richelson, E | 1 |
| Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR | 1 |
| Gregor, KJ; James, SP; Way, K; Young, CH | 1 |
| Gorman, JM | 1 |
| Cohen, CI; Trappler, B | 1 |
| Edwards, IR; Fletcher, AP; Lindquist, M; Pettersson, M; Sanderson, JH; Schou, JS; Stahl, MM; Taylor, NF | 1 |
| Buesching, DP; Croghan, TW; Crown, WH; Heiligenstein, JH; Hylan, TR; Melfi, CA; Meneades, L | 2 |
| Brochu, J; Cook, L; Feldkamp, M; Koren, G; Kulin, NA; Matsui, D; Ormond, K; Pastuszak, A; Rieder, M; Sage, SR; Schick-Boschetto, B; Spivey, G; Stein-Schechman, AK | 1 |
| Fawcett, J; Mitchell, S; Zajecka, J | 1 |
| Grimes, JB; Hines, A; Labbate, LA; Pollack, MH | 1 |
| Andrews, W; Barrett, E; Parker, G | 1 |
| Arana, GW; Grimes, JB; Labbate, LA | 1 |
| Grush, LR | 1 |
| Ascroft, RC; Fava, M; Hoog, SL; Krebs, WB; Rosenbaum, JF | 1 |
| Beach, K; Dougherty, D; Hilal, R; Nesbitt, L; Sallee, FR | 1 |
| Amey, M; Baumann, P; Bouchoux, G; Cochard, N; Eap, CB; Savary, L | 1 |
| Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P | 1 |
| Hengeveld, MW; Olivier, B; Waldinger, MD; Zwinderman, AH | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Roose, SP; Suthers, KM | 1 |
| Di Giovanni, G; Di Mascio, M; Di Matteo, V; Esposito, E; Prisco, S | 1 |
| Barbey, JT; Roose, SP | 1 |
| Arlinghaus, KA; Clearman, RR; George, MS; Kotrla, KJ; Nahas, Z | 1 |
| Thompson, C | 1 |
| Stahl, SM | 1 |
| Dekeyne, A; Girardon, S; Gobert, A; Millan, MJ | 1 |
| Anand, VS; Dewan, MJ | 1 |
| Voris, JC | 1 |
| Alfaro, CL; Ereshefsky, L; Lam, YW; Simpson, J | 2 |
| Phillips, KA; Rothschild, AJ | 1 |
| Bagby, RM; Joffe, RT; Kennedy, SH; Levitan, RD; Levitt, AJ | 1 |
| Carleborg, L; Hägg, S; Ohman, R; Spigset, O | 1 |
| Sheehan, DV | 1 |
| Bakker, A | 1 |
| Farvolden, P; Mancini, C; Oakman, JM; Van Ameringen, M | 1 |
| Hensley, PL; Nurnberg, HG; Paine, SS; Thompson, PM | 1 |
| Galin, RS; Robison, LM; Sclar, DA; Skaer, TL | 1 |
| Hensley, PL; Nurnberg, HG; Thompson, PM | 1 |
| Berndt, ER; Colucci, S; Grudzinski, AN; Miceli, R; Russell, JM | 1 |
| Benmansour, S; Cecchi, M; Frazer, A; Gerhardt, GA; Gould, GG; Javors, MA; Morilak, DA | 1 |
| Seiden, LS; Sokolowski, JD | 1 |
| McMahon, CG; Samali, R | 1 |
| Folstein, S; Larson, M | 1 |
| Amsterdam, J; Apter, J; Fava, M; Londborg, P; Michelson, D; Pagh, L; Tamura, R | 1 |
| Härtter, S; Hiemke, C | 1 |
| Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD | 1 |
| Han, JH; Kim, SC; Lee, MY; Seo, KK | 1 |
| Hostetter, A; Llewellyn, A; McLaughlin, E; Stowe, ZN; Strader, JR | 1 |
| Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
| Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH | 1 |
| Fava, M; Hoog, SL; Kopp, JB; Nilsson, ME; Rosenbaum, JF; Tepner, RG | 1 |
| Gentilini, G; Lopez-Silva, S; Lucca, A; Soldarini, A | 1 |
| Anthony, JP; Neumaier, JF; Sexton, TJ | 1 |
| Arancio, C; Bellodi, L; Bertani, A; Caldirola, D; Perna, G | 1 |
| Baier, D; Kohnen, R; Philipp, M; Tiller, JW | 1 |
| Bongiorno, F; Franchini, L; Rossini, D; Smeraldi, E; Spagnolo, C; Zanardi, R | 1 |
| Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL | 1 |
| Deslandes, PN; Pache, DM; Sewell, RD; Subhan, F | 1 |
| Fava, M; Hoog, SL; Judge, R; Koke, SC; Nilsson, ME | 1 |
| Aberg-Wistedt, A; Agren, H; Akerblad, AC; Bengtsson, F; Ekselius, L | 1 |
| Caputo, RM; Stern, S; Votolato, NA | 1 |
| Ancione, M; Avenoso, A; Facciolá, G; Madia, A; Salemi, M; Scordo, MG; Spina, E | 1 |
| Fitzgerald, F; Glod, CA; Lynch, A | 1 |
| Aberg-Wistedt, A; Khoury, AE; Stain-Malmgren, R; Tham, A | 1 |
| Birnbaum, AK; Nelson, MH; Remmel, RP | 1 |
| Dewa, CS; Goering, P; Hoch, JS | 1 |
| Cook, IA; Leuchter, AF | 1 |
| Abdel-Hamid, IA; El Gilany, AH; El Naggar, EA | 1 |
| Panzarino, PJ; Xuan, J | 1 |
| Kim, SC; Lee, MY; Seo, KK | 1 |
| Olivier, B; Waldinger, MD; Zwinderman, AH | 1 |
| Bergsholm, YK; Bøhler, E; Nordeng, H; Spigset, O | 1 |
| Altshuler, L; Brunhuber, MV; Fukuchi, A; Hendrick, V; Wertheimer, A; Widawski, M | 1 |
| Ramasubbu, R | 1 |
| Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S | 1 |
| Kruizinga, MJ; Riedel, WJ; Schmitt, JA | 1 |
| Clary, CM; Colucci, SV; Grudzinski, AN; Miceli, RJ; Roy-Byrne, PP; Xu, Y | 1 |
| Furlan, PM; Kallan, MJ; Katz, I; Lucki, I; Pollock, BG; Ten Have, T | 1 |
| Dolor, R; Eckert, GJ; Gilsenan, A; Hays, R; Kroenke, K; Stang, P; Swindle, R; Weinberger, M; West, SL; Zhou, XH | 1 |
| Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S | 1 |
| Stammler, F; Ysermann, M | 1 |
| Bogetto, F; Gandolfo, S; Maina, G; Vitalucci, A | 1 |
| Bauer, MS; Glick, HA; Onesirosan, P; Polsky, D | 1 |
| Fava, M; Gonzales, JS; Hoog, SL; Judge, RA; Kopp, JB; Nilsson, ME | 1 |
| Boulton, DW; DeVane, CL; Goldman, J; Liston, HL; Markowitz, JS; Risch, SC | 1 |
| Azadian, AG; Warnock, CA | 1 |
| Bagby, RM; Kennedy, SH; Vanderkooy, JD | 1 |
| Brown, EB; Gonzales, JS; Miner, CM; Munir, R | 1 |
| Dane, FC; Elliott, RL | 1 |
| Stopa, SF | 1 |
| Culpepper, L; Heeren, T | 1 |
| Keeley, R | 1 |
| Cronholm, P; Straton, JB | 1 |
| Cullen, N; Lexell, J; Zafonte, RD | 1 |
| Droogmans, G; Maertens, C; Nilius, B; Verbesselt, R | 1 |
| Alfaro, CL; Ereshefsky, L; Gaedigk, A; Lam, YW; Simpson, J | 1 |
| Kruizinga, MJ; Ramaekers, JG; Riedel, WJ; Schmitt, JA; van Boxtel, MP; Vuurman, EF | 1 |
| Kline, NA; Matloff, JL; Stein, MB | 1 |
| Buckland, P; Deslandes, PN; Pache, DM; Sewell, RD | 1 |
| De La Fuente, JA; De Las Cuevas, C; Sanz, EJ | 1 |
| Anderson, TA; Dobscha, SK; Hauser, P; Hoffman, WF; Snodgrass, LS; Turner, EH; Winterbottom, LM | 1 |
| Rickels, K; Rynn, M | 1 |
| Lo Sasso, AT; Sheffield, RE; Way, K; Young, CH | 1 |
| Altshuler, LL; Haynes, D; Hendrick, V; Hwang, S; Lee, E; Stowe, ZN | 1 |
| Varley, CK | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Akin, A; Chaturvedi, AK | 1 |
| Rosner, MH | 1 |
| Kim, SW; Lee, SH; Paick, JS | 1 |
| Anand, A; Berman, RM; Charney, DS; Lynch-Colonese, K; Perry, EB; Sanacora, G | 1 |
| Bergamasco, B; Cicolin, A; Fattori, E; Guastamacchia, G; Lanotte, MM; Lopiano, L; Makrydakis, G; Mutani, R; Tavella, A; Terreni, A; Torre, E; Zibetti, M | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Alkin, T; Bandelow, B; Behnke, K; Clary, CM; Goebel, C; Hendriks, GJ; Lenoir, S | 1 |
| Carella, A; Cheok, A; Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Potter, WZ; Sagrati, S; Spencer, EP; Wilson, AA | 1 |
| Danielyan, A; Kowatch, RA; Pathak, S | 1 |
| Cryan, JF; Dalvi, A; Friedland, JC; Hirsch, BR; Jin, SH; Lucki, I; O'Leary, OF; Ouyang, M; Page, ME; Thomas, SA | 1 |
| Broderick, GA; Dmochowski, RR; Heaton, JP; Jarow, J; Lue, TF; Montague, DK; Nehra, A; Sharlip, ID | 1 |
| Brown, EB; Joliat, MJ; Miner, CM | 1 |
| Eckert, G; Greco, T; Kroenke, K | 1 |
| Aberg-Wistedt, A; Agren, H; Akerblad, AC; Bengtsson, F; Höglund, P; Reis, M | 1 |
| Eichner, SF; Jones, JR; Moore, ML | 1 |
| Aamo, TO; Berle, JØ; Breilid, H; Spigset, O; Steen, VM; Zahlsen, K | 1 |
| Armbrust, KL; Black, MC; Henry, TB; Kwon, JW | 1 |
| Hirano, K; Kagawa, Y; Kimura, R; Maruyama, S; Yamada, S | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Elfving, B; Wiborg, O | 1 |
| Ball, SG; Goddard, AW; Kuhn, A; Shekhar, A; Wall, D | 1 |
| Hashimoto, H; Hirano, K; Kato, Y; Kimura, R; Sugimoto, Y; Uchida, S; Yamada, J; Yamada, S | 1 |
| Harrison, D; Meng, F; Mullins, CD; Shaya, FT; Wang, J | 1 |
| Isbester, PK; Salsbury, JS | 1 |
| Martényi, F | 1 |
| Briley, KA; Goodale, ES; Gopal, KV; Hendea, OM | 1 |
| Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM | 1 |
| Bonikovski, V; Futuro-Neto, HA; Pires, JG | 1 |
| Carrasco, JL; Sandner, C | 1 |
| Campanella, D; Carano, A; Cicconetti, A; D'Amico, M; De Berardis, D; Ferro, FM; Gambi, F; La Rovere, R; Mancini, E; Peca, S; Penna, L; Salerno, RM; Sepede, G | 1 |
| Arora, S; DeBattista, C; Fava, M; Hughes, RJ; Thase, ME | 1 |
| Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T | 1 |
| Davidson, JR | 2 |
| de Abajo, FJ; Madurga, M; Montero, D; Rodríguez, LA | 1 |
| Doherty, B; Hannigan, B; Joyce, C; Leslie, JC; McClean, S; McKenna, HP; O'Kane, E; Smyth, WF | 1 |
| Dinan, TG; O'Brien, SM; Scott, LV | 1 |
| Bron, MS; Meng, F; Mullins, CD; Shaya, FT; Wang, J | 1 |
| Greenhill, LL; Moreno, C; Roche, AM | 1 |
| Ayestarán, A; Carrera, M; García-Unzueta, MT; Herrán, A; Hoyuela, F; Ramírez, ML; Rodríguez-Cabo, B; Sierra-Biddle, D; Vázquez-Barquero, JL | 1 |
| Celik, L; Kaynak, S; Kaynak, T; Kocak, N; Ozerdem, A | 1 |
| Bailly, D | 1 |
| Eastwood, BJ; Jones, CK; Need, AB; Shannon, HE | 1 |
| Haro, JM; Peñarrubia, MT; Pinto-Meza, A; Serrano-Blanco, A; Suárez, D | 1 |
| Choi, J; Golbeck, AL; Neff, M; Preskorn, SH; Shah, R | 1 |
| Ahn, SC; Choi, TK; Lee, SH; Lee, YJ; Suh, SY; Yook, KH | 1 |
| Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R | 1 |
| Connor, K; Davidson, JR; Vaishnavi, S | 1 |
| Baharav, E; Bar, M; Gil-Ad, I; Korov, I; Lomnitski, L; Taler, M; Weizman, A; Zolokov, A | 1 |
| Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G | 1 |
| Hetrick, S; McKenzie, J; Merry, S; Proctor, M; Sindahl, P | 1 |
| Ben-Shushan, G; Gil-Ad, I; Hershkovitz, A; Isaac, R; Levkovitz, Y; Ronen, D; Shvartsman, D; Weizman, A; Zick, Y | 1 |
| Drago, F; Leggio, GM; Micale, V | 1 |
| Bekele, NB; Shih, YC; Xu, Y | 1 |
| Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Cooke, C; Gardner, D; Kisely, S; Sketris, I; Smith, AJ; Tett, SE | 1 |
| Holman, JR; Kimmer, SL; Lo, V; Mercado, MG; Wanserski, G | 1 |
| Baharav, E; Bar, M; Gil-Ad, I; Grunbaum-Novak, N; Korob, I; Lomnitski, L; Taler, M; Weizman, A | 1 |
| Ağargün, MY; Aşkin, R; Aydin, A; Beşiroğlu, L; Uğuz, F; Yilmaz, E | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Ermani, M; Freo, U; Merico, A; Ori, C | 1 |
| Mitchell, J; Wang, GK; Wang, SY | 1 |
| Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R | 1 |
| Brennum, LT; Kreilgaard, M; Sánchez, C; Smith, DG | 1 |
| Bar, M; Gil-Ad, I; Lomnitski, L; Luria, D; Ram, E; Taler, M; Weizman, A; Zolokov, A | 1 |
| Terao, T | 1 |
| Dotan, Y; Pillar, G; Suraiya, S | 1 |
| Freeman, MP | 1 |
| Gale, CK; Millichamp, J | 1 |
| Ahrold, TK; Meston, CM | 1 |
| Carrilho, E; Catai, AP; Lanças, FM; Queiroz, ME | 1 |
| De Koning, FH; Derijks, HJ; Egberts, AC; Heerdink, ER; Janknegt, R; Krekels, MM; Looij, BJ | 1 |
| Amit, BH; Bar, M; Gil-Ad, I; Taler, M; Weizman, A; Zolokov, A | 1 |
| Lanza di Scalea, T; Wisner, KL | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Muci, E; Ozyavuz, R; Yaris, E | 1 |
| Crain, AL; Godlevsky, OV; O'Connor, PJ; Wei, F; Whitebird, RR | 1 |
| Oros, MM; Reynolds, GP; Yevtushenko, OO | 1 |
| DeVeaugh-Geiss, AM; Gaynes, BN; Kroenke, K; Miller, WC; Sleath, B; West, SL | 1 |
| Iwata, N; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Naitoh, H; Nakamura, J; Okochi, T; Okumura, T; Ozaki, N; Tsunoka, T; Yamanouchi, Y; Yoshimura, R | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Gricar, J; Rendas-Baum, R; Wallenstein, GV; Yang, M | 1 |
| Charles, D; Fava, M; Papakostas, GI | 1 |
| Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS | 1 |
| Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
| Garner, B; Hetrick, SE; Parslow, R; Purcell, R | 1 |
| Mochcovitch, MD; Nardi, AE | 1 |
| Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M | 1 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Boku, S; Inoue, T; Izumi, T; Kakuta, A; Kitaichi, Y; Koyama, T; Nakagawa, S | 1 |
| Dobzhenko, MN; Shchepotin, IB; Zotov, AS | 1 |
| Hori, H; Ikenouchi-Sugita, A; Iwata, N; Kishi, T; Nakamura, J; Otani, K; Suzuki, A; Umene-Nakano, W; Yoshimura, R | 1 |
| Beste, J; Blackwell, JC; Patel, BN | 1 |
| Fukuo, Y; Inada, T; Iwata, N; Kawashima, K; Kishi, T; Kitajima, T; Kushima, I; Matsunaga, S; Naitoh, H; Nakamura, J; Okochi, T; Ozaki, N; Umene-Nakano, W; Yoshimura, R | 1 |
| Abe, T; Hirano, J; Kashima, H; Mimura, M; Nakajima, S; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K; Yagihashi, T | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Abaitua, I; Alonso-Ferreira, V; Hens, MJ; Posada de la Paz, M; Villaverde-Hueso, A | 1 |
| Chamielec, M; Gałecki, P; Talarowska, M; Zboralski, K | 1 |
| Maraschin, M; Rodrigues, AL; Tasca, CI; Zeni, AL; Zomkowski, AD | 1 |
| Akamine, Y; Kaneko, S; Niioka, T; Saruwatari, J; Takashima, A; Uno, T; Yasui-Furukori, N | 1 |
| Dahmen, N; Engel, A; Gerbaulet, M; Hiemke, C | 1 |
| Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA | 1 |
| Boku, S; Fujisawa, D; Honda, M; Inoue, T; Ishikane, T; Ito, K; Kawamura, K; Koyama, T; Matsubara, R; Ono, Y; Sasaki, K; Shinohara, K; Suzuki, T; Tsuchiya, K | 1 |
| Cortés, JM; Hidalgo, M; Jönsson, JÅ; Larsson, E; Sagristà, E; Salvadó, V | 1 |
| Hori, H; Ikenouchi-Sugita, A; Iwata, N; Katsuki, A; Kishi, T; Nakamura, J; Umene-Nakano, W; Yoshimura, R | 1 |
| Cox, GR; Hetrick, SE; McKenzie, JE; Merry, SN; Simmons, MB | 1 |
| Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE | 1 |
| Boura-Halfon, S; Gurevitch, D; Isaac, R; Levkovitz, Y; Shainskaya, A; Zick, Y | 1 |
| Gorman, DA; Lam, D; Patten, S; Pringsheim, T | 1 |
| Filov, I; Gerazova, VP; Marinov, P; Novotni, A; Ristevska-Dimitrovska, G; Shishkov, R; Stefanovski, B; Vujovik, V | 1 |
| Park, YM | 1 |
| Cekmen, M; Dursun, M; Kirecci, SL; Otunctemur, A; Ozbek, E; Ozcan, L; Ozdogan, HK | 1 |
| Cho, HY; Kim, JE; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Seo, MK; Seol, W | 1 |
| Gurbuz, ZG; Gurdal, H; Kirecci, SL; Simsek, A; Usanmaz, S; Yuksel, A | 1 |
| Montgomery, SA; Reines, EH; Sanchez, C | 1 |
| Degirmencioglu, S; Gurbuz, ZG; Kirecci, SL; Mimaroglu, S; Simsek, A; Vural, P; Yuksel, A | 2 |
| Sato, Y | 1 |
| Amano, T | 1 |
| Gupta, MA | 1 |
| Handley, AP; Williams, M | 1 |
| Futuro Neto, HA; Pires, JG; Ramage, AG; Santuzzi, CH; Silva, NF; Tiradentes, RV | 1 |
| Becker, T; Koesters, M; Ma, Y; Zhang, Y | 1 |
| Howard, LM; Karia, AM; McGeown, HR; Molyneaux, E; Trevillion, K | 1 |
| IsHak, WW; Karamians, R; Peselow, ED; Pizano, D; Tobia, G | 1 |
| Hermann, M; Molden, E; Waade, RB | 1 |
| Akindipe, TO; Ipser, JC; Sager, C; Stein, DJ; Wilson, D | 1 |
| Dueñas, H; Haro, JM; Hong, J; Moneta, MV; Montgomery, W; Novick, D; Peng, X | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D | 1 |
| Halling-Sørensen, B; Hansen, CH; Jacobsen, NW; Nellemann, C; Styrishave, B | 1 |
| Patterson, B; Van Ameringen, M | 1 |
| Egashira, N; Kuwahara, J; Masuda, S; Ueda, M; Ushio, S; Yamada, T; Zukeyama, N | 1 |
| Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL | 1 |
| Azrael, D; Bushnell, GA; Miller, M; Pate, V; Stürmer, T; Swanson, SA; White, A | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Arakawa, R; Kim, W; Ogawa, K; Okubo, Y; Sakayori, T; Tateno, A | 1 |
| Andreão, RV; Benseñor, IM; Bittencourt, MS; Brunoni, AR; Dantas, EM; Fráguas, R; Kemp, AH; Koenig, J; Lotufo, PA; Mill, JG; Nunes, MA; Ribeiro, AL; Thayer, JF | 1 |
| Eriksson, E; Hieronymus, F; Nilsson, S | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| IsHak, WW; Naghdechi, L | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
| Arpaci, N; Uguz, F | 1 |
| Mai, SM; Xiang, YT; Yang, XH; Zhang, YF; Zheng, W; Zhong, HQ | 1 |
| Adamczak, SK; Bury, TBS; Donovan, EE; Fong, PP; Lambert, OJ; Palmucci, JR | 1 |
| Bae, YM; Bang, H; Choi, IW; Firth, AL; Kim, HS; Kim, HW; Li, H; Park, WS; Shin, SE | 1 |
| Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B | 1 |
| Campos, RS; Cavalcanti, BC; Costa Silva, RA; da Cruz Fonseca, SG; da Silva Gaspar, B; da Silva, AR; da Silva, CR; de Andrade Neto, JB; de Lucena, DF; de Moraes, MO; do Nascimento, FBSA; Gaspar, DM; Grangeiro, TB; Josino, MAA; Nobre Júnior, HV; Sampaio, LS | 1 |
| Araujo, M; Benevent, J; Bondon-Guitton, E; Chebane, L; Durrieu, G; Montastruc, F; Montastruc, JL; Ojero-Senard, A | 1 |
| Cabrera, RM; Finnell, RH; Parker, M; Pomerantz, Y; Vichier-Guerre, C | 1 |
| Emilsson, JF; Eriksson, E; Hieronymus, F; Lisinski, A; Näslund, J; Nilsson, S | 1 |
| Bartova, L; Dold, M; Kasper, S; Rupprecht, R | 1 |
| He, JC; Pu, ZP; Xia, JM; Xie, W | 1 |
| Bird, TD; Caffrey, CR; Currey, H; Eichenberger, RM; Hawdon, JM; Kraemer, BC; Leasure, C; Liachko, NF; Loukas, A; Roberts, WM; Robinson, KJ; Saxton, AD; Suzuki, BM; Wangchuk, P; Weeks, JC | 1 |
| Coleman, JA; Gouaux, E | 1 |
| Beyer, JL; Johnson, KG | 1 |
| Bogdanova, OV; D'Anci, KE; Kanekar, S; Olson, PR; Ombach, HJ; Petersen, M; Renshaw, CE; Renshaw, PF; Sheth, CS; Sung, YH | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Gao, YL; He, B | 1 |
| Gui, J; Maguen, S; Schnurr, PP; Shiner, B; Watts, BV; Westgate, CL; Young-Xu, Y | 1 |
| Carson-Chahhoud, KV; Pollok, J; van Agteren, JE | 1 |
| Bassi, M; Cauli, G; Gala, C; Iapichino, E; Marconi, AM; Quartieri Bollani, M; Rucci, P | 1 |
| Aitchison, KJ; Binder, EB; Carrillo-Roa, T; Cattaneo, A; DeModena, A; Henigsberg, N; Kelsoe, JR; Leckband, SG; Liu, JJ; McCarthy, M; Mors, O; Ren, H; Rietschel, M; Shekhtman, T; Wei, YB | 1 |
| Barbui, C; Bennie, M; Godman, B; Hurding, S; Johnson, CF; Kurdi, A; Leporowski, A; MacBride-Stewart, S; McCabe, H; Morton, A | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Chen, L; Cheng, S; Guo, S; Xu, H | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Nilsson, S | 1 |
| Alag, P; Balasubramaniam, M; Gupta, A; Gupta, S; Joshi, P; Maher, S; Tampi, D; Tampi, RR; Young, J | 1 |
| Alsaab, S; Cobb, C; Haidari, M; Mansani, S; Ponds, D; Romero, L | 1 |
| Doucet, N; Hudon Thibeault, AA; López de Los Santos, Y; Sanderson, JT; Vaillancourt, C | 1 |
| Nasrallah, HA; Sagarwala, R | 1 |
| Cabrera, RM; Kim, J; Law, E; Linda Lin, Y; Wlodarczyk, BJ | 1 |
| Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X | 1 |
| Bates, DW; Buckeridge, DL; Dixon, WG; Girard, N; Haas, JS; Habib, B; Iqbal, U; Li, J; Sheppard, T; Tamblyn, R | 1 |
| Esposito, DB; Petersen, JM; Werler, MM | 1 |
| Baker, A; Bisson, JI; Dekker, W; Hoskins, MD | 1 |
| de Moraes Costa, G; Mello, CF; Soares Barros, AJ; Zanatta, FB; Ziegelmann, PK | 1 |
| Cornelius, SL; Gui, J; Hoyt, JE; Leonard, CE; Schnurr, PP; Shiner, B; Watts, BV; Young-Xu, Y | 1 |
| Hui, A | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Wallerstedt, SM | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| Kamış, GZ; Kurhan, F | 1 |
| Brouwer, JMJL; Buunk, AM; de Boer-Veger, NJ; Deneer, VHM; Guchelaar, HJ; Houwink, EJF; Mulder, H; Nijenhuis, M; Rongen, GAPJM; Soree, B; Swen, JJ; van Schaik, RHN; van Westrhenen, R; Weide, JV; Wilffert, B | 1 |
| Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA | 1 |
| Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A | 1 |
| Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A | 1 |
| Giraldi, A; Hutters, CL | 1 |
| Bracke, F; Frieling, H; Leffler, A | 1 |
| Dai, Y; Gao, H; Huang, Y; Jiang, H; Liu, Q; Wang, M; Zhang, X | 1 |
| Kenda, M; Sollner Dolenc, M; Zore, T | 1 |
| Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC | 1 |
| Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S | 1 |
| Arasu, R; Badeshae, S; Chen, W; Furlong, Y | 1 |
| Gasparyan, A; Manzanares, J; Navarrete, F; Navarro, D | 1 |
| Azoulay, L; Cao, TXD; Fergusson, E; Filliter, C; Montastruc, F; Rej, S; Renoux, C; Yu, OHY | 1 |
| Chen, Y; Cui, W; Gong, L; Guo, L; Liu, X; Lu, J; Mao, Y; Mei, D; Shen, H; Wang, C; Wu, X; Yu, T; Zhang, J; Zhou, W; Zhou, Y | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Amada, N; Futamura, T; Hirose, T; Kakumoto, Y; Kikuchi, T; Maeda, K; Suzuki, M | 1 |
| Alexandre, C; Alexandre, J; Desaunay, P; Dreyfus, M; Eude, LG; Fedrizzi, S; Guénolé, F; Uguz, F | 1 |
| Chen, M; Fan, J; Guo, C; Liu, W; Liu, Y; Lu, H; Xu, J; Yang, J; Zhang, H | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
88 review(s) available for paroxetine and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction.
Topics: Antibodies; Ebolavirus; Glycoproteins; Hemorrhagic Fever, Ebola; Humans; Molecular Docking Simulation; Niemann-Pick C1 Protein; Protein Binding; Small Molecule Libraries; Virus Internalization | 2021 |
Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Depressive Disorder; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
Pharmacokinetics of the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
Clinical overview of serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline; Zimeldine | 1990 |
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism | 1995 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Topics: 1-Naphthylamine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Half-Life; Humans; Metabolic Clearance Rate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline | 1993 |
[New antidepressive agents].
Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Use of serotonin selective reuptake inhibitors in geriatric depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Antidepressants in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Psychotherapy; Sertraline; Sexual Dysfunctions, Psychological | 1996 |
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Female; Fluoxetine; Fluvoxamine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Depression: making the diagnosis and using SSRIs in the older patient.
Topics: 1-Naphthylamine; Adult; Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
Topics: 1-Naphthylamine; Animals; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Movement disorders associated with the serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 1996 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Antidepressant response in late-life depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
SSRI safety in overdose.
Topics: Adult; Child; Citalopram; Drug Overdose; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Poison Control Centers; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Current concepts in the treatment of panic disorder.
Topics: Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Pharmacological treatment of premature ejaculation.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Dysfunction, Physiological | 1999 |
Pharmacokinetics of selective serotonin reuptake inhibitors.
Topics: Citalopram; Clinical Trials as Topic; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; Corynebacterium; Drug Synergism; Fluoxetine; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Psychopharmacologic treatment of adolescent depression.
Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2001 |
Serotonin agents in the treatment of acquired brain injury.
Topics: Brain Injuries; Citalopram; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Injury Severity Score; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Topics: Autistic Disorder; Citalopram; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
[Posttraumatic stress disorder (PTSD)].
Topics: Antidepressive Agents, Second-Generation; Catecholamines; Comorbidity; Controlled Clinical Trials as Topic; Crime Victims; Female; Humans; Hypothalamo-Hypophyseal System; Incidence; Life Change Events; Male; Paroxetine; Pituitary-Adrenal System; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans Disability Claims; Vietnam Conflict; World War I; World War II | 2004 |
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Fluoxetine; Fluvoxamine; Humans; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Pharmacologic treatment of acute and chronic stress following trauma: 2006.
Topics: Algorithms; Anxiety Disorders; Comorbidity; Depressive Disorder; Disasters; Drug Administration Schedule; Humans; Internet; Paroxetine; Psychotropic Drugs; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Survivors; Treatment Outcome | 2006 |
Antidepressants and risk of upper gastrointestinal bleeding.
Topics: Adverse Drug Reaction Reporting Systems; Age Factors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Blood Platelets; Drug Interactions; Epidemiologic Studies; Fluoxetine; Gastrointestinal Hemorrhage; Humans; Paroxetine; Platelet Aggregation; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Upper Gastrointestinal Tract | 2006 |
Pharmacotherapy of child and adolescent depression.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Sertraline; Social Behavior | 2006 |
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted | 2006 |
Pharmacotherapy of social anxiety disorder: what does the evidence tell us?
Topics: Clonazepam; Comorbidity; Drug Therapy, Combination; Humans; Paroxetine; Phobic Disorders; Psychotropic Drugs; Secondary Prevention; Sertraline; Treatment Outcome | 2006 |
Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2007 |
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2008 |
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
Generalised anxiety disorder.
Topics: Anxiety Disorders; Citalopram; Cognitive Behavioral Therapy; Double-Blind Method; Humans; Paroxetine; Remission Induction; Sertraline | 2007 |
Antidepressant medication use during breastfeeding.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Humans; Infant; Lactation; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD).
Topics: Adolescent; Adult; Child; Child Abuse, Sexual; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Paroxetine; Randomized Controlled Trials as Topic; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2010 |
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens | 2010 |
[Selective serotonin reuptake inhibitors and mammary pathologies].
Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride | 2012 |
Newer generation antidepressants for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Induction Chemotherapy; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2012 |
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation | 2012 |
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Topics: Allosteric Site; Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder, Major; Drug Interactions; Evidence-Based Medicine; Humans; Models, Biological; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2014 |
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride | 2015 |
A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; China; Citalopram; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Antidepressant treatment for postnatal depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression, Postpartum; Female; Fluoxetine; Humans; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Topics: Alcohol-Related Disorders; Anxiety; Anxiety Disorders; Buspirone; Comorbidity; Desipramine; Humans; Paroxetine; Phobia, Social; Publication Bias; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2015 |
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride | 2015 |
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; China; Depressive Disorder, Major; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Sertraline; Treatment Outcome; Young Adult | 2016 |
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride | 2017 |
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Citalopram; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2017 |
Advances in Pharmacotherapy of Late-Life Depression.
Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine | 2018 |
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Topics: Antidepressive Agents, Tricyclic; Depression; Dizziness; Dyspnea; Exercise Tolerance; Forced Expiratory Volume; Humans; Nausea; Nortriptyline; Paroxetine; Placebos; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2018 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Cardiovascular Diseases; China; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Antidepressants for anxiety disorders in late-life: A systematic review.
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Citalopram; Duloxetine Hydrochloride; Humans; Late Onset Disorders; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review.
Topics: Biomarkers; Humans; Hydrocortisone; Inflammation; Interleukin-1beta; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2019 |
Pharmacological treatments for adults with post-traumatic stress disorder: A network meta-analysis of comparative efficacy and acceptability.
Topics: Adult; Humans; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2020 |
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome | 2020 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Are all antidepressants the same? The consumer has a point.
Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2023 |
[Sexual side effects from treatment with SSRI].
Topics: Citalopram; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 2022 |
Comparison of fluoxetine with other selective serotonin reuptake inhibitors in the treatment of premature ejaculation: A systematic review and meta-analysis.
Topics: Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2022 |
Sertraline-Induced Tics: A Case Report and Narrative Review.
Topics: Adolescent; Adult; Anxiety; Female; Humans; Observational Studies as Topic; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tics | 2023 |
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies.
Topics: Animals; Anxiety Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses.
Topics: Antidepressive Agents; Child; Female; Fluoxetine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Premature Birth; Risk Assessment; Sertraline | 2023 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
63 trial(s) available for paroxetine and sertraline
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological | 1995 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Response to an open trial of a second SSRI in major depression.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
Topics: 1-Naphthylamine; Delusions; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders | 1997 |
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Impulsive Behavior; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe; Treatment Outcome | 1997 |
Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial.
Topics: 1-Naphthylamine; Adolescent; Aggression; Female; Fluoxetine; Humans; Inpatients; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Area Under Curve; Cross-Over Studies; Desipramine; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; Paroxetine; Sertraline | 1997 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Use of SSRIs in "very old" depressed nursing home residents.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric | 1998 |
Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders.
Topics: 1-Naphthylamine; Adult; Anxiety; Ejaculation; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm; Paroxetine; Penile Erection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 1998 |
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Health Status; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1998 |
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.
Topics: Adult; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Reference Values; Sertraline | 1999 |
Selective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: evidence of non-specificity.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents; Depressive Disorder, Major; Desipramine; Female; Humans; Male; Paroxetine; Personality; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Medical Records; Mental Disorders; Middle Aged; Mood Disorders; Paroxetine; Retrospective Studies; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
Topics: Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Humans; Isoenzymes; Paroxetine; Phenotype; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
Topics: Adult; Biomarkers; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hemodynamics; Hormones; Humans; Male; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Substance Withdrawal Syndrome | 2000 |
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride | 2000 |
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Carbon Dioxide; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Multivariate Analysis; Panic Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors | 2000 |
Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2000 |
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2000 |
Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy.
Topics: Adolescent; Adult; Analysis of Variance; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Personality Disorders; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline.
Topics: Adult; Clozapine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Psychotic Disorders; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 2000 |
Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
Topics: Administration, Oral; Adult; Depressive Disorder; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline; Treatment Outcome | 2001 |
Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation.
Topics: Adult; Antidepressive Agents; Clomipramine; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Paroxetine; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sertraline; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Time Factors | 2001 |
Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents; Chi-Square Distribution; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Paroxetine; Piperazines; Placebos; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles | 2001 |
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors.
Topics: Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Paroxetine; Retention, Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline; Verbal Behavior; Verbal Learning | 2001 |
Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.
Topics: Aged; Cognition; Double-Blind Method; Health Status; Humans; Mental Recall; Paroxetine; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2001 |
Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
Topics: Amisulpride; Antipsychotic Agents; Burning Mouth Syndrome; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Sulpiride; Treatment Outcome | 2002 |
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Personality Inventory; Sertraline; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2002 |
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.
Topics: Adolescent; Adult; Cytochrome P-450 CYP2D6 Inhibitors; Female; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2002 |
Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2002 |
CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.
Topics: Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Fluvoxamine; Genotype; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.
Topics: Adult; Attention; Cross-Over Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
Topics: Antipsychotic Agents; Benzodiazepines; Combat Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Paroxetine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Treatment Outcome | 2002 |
Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Connecticut; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Hospitals, Veterans; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Veterans | 2004 |
Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
Topics: Acute Disease; Adult; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
The outcome of physical symptoms with treatment of depression.
Topics: Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Status; Health Surveys; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders; Treatment Outcome | 2004 |
Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.
Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Monitoring; Female; Half-Life; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
Topics: Adult; Anxiety Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Paroxetine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Selective serotonin reuptake inhibitors treatment effects on auditory measures in depressed female subjects.
Topics: Acoustic Impedance Tests; Adult; Brain; Depression; Dichotic Listening Tests; Evoked Potentials, Auditory, Brain Stem; Female; Fluoxetine; Humans; Loudness Perception; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Speech Perception | 2005 |
Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial.
Topics: Adult; Agoraphobia; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure | 2006 |
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fatigue; Female; Humans; Male; Middle Aged; Modafinil; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans; Meditation; Paroxetine; Program Development; Self Care; Sertraline; Stress, Psychological; Surveys and Questionnaires | 2007 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
Topics: Adrenergic Agents; Adult; Arousal; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Ephedrine; Female; Fluoxetine; Humans; Norepinephrine; Orgasm; Paroxetine; Premedication; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Behavior; Sexual Dysfunction, Physiological; Sympathetic Nervous System | 2009 |
Depression and comorbid panic in primary care patients.
Topics: Adult; Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Panic Disorder; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2010 |
Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Sertraline; Time Factors; Treatment Outcome | 2011 |
Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
Topics: Adolescent; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Drug Interactions; Female; Fluvoxamine; Half-Life; Humans; Intestine, Small; Liver; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Terfenadine; Young Adult | 2012 |
Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Severity of Illness Index; Treatment Outcome | 2012 |
Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline | 2012 |
Relevance of serum nitric oxide levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation: decreased nitric oxide is associated with premature ejaculation.
Topics: Adult; Case-Control Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Nitric Oxide; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2014 |
Relevance of seminal plasma nitric oxide levels and the efficacy of SSRI treatment on lifelong premature ejaculation.
Topics: Adult; Double-Blind Method; Ejaculation; Humans; Male; Nitric Oxide; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Semen; Sertraline; Treatment Outcome | 2014 |
Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Adult; Fluoxetine; Humans; Male; Melatonin; Middle Aged; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2014 |
Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period.
Topics: Adult; Antidepressive Agents; Anxiety; Combined Modality Therapy; Depression; Depression, Postpartum; Female; Humans; Longitudinal Studies; Mothers; Paroxetine; Patient Acceptance of Health Care; Perinatal Care; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Factors; Sertraline; Treatment Outcome | 2019 |
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
254 other study(ies) available for paroxetine and sertraline
| Article | Year |
|---|---|
Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
Topics: Amino Alcohols; Animals; Antidepressive Agents; Dopamine; Humans; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Serotonin; Species Specificity | 1998 |
Inhibition of P-glycoprotein by newer antidepressants.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
An antidepressant that extends lifespan in adult Caenorhabditis elegans.
Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
Topics: Animals; Antidepressive Agents; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Mice; Motor Activity; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Ebolavirus; Glycoproteins; Hemorrhagic Fever, Ebola; Models, Molecular; Protein Conformation; Thermodynamics; Vero Cells; Virus Internalization | 2018 |
Discovery of potent ebola entry inhibitors with (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold.
Topics: Antiviral Agents; Ebolavirus; Hemorrhagic Fever, Ebola; HIV Fusion Inhibitors; Humans; Molecular Docking Simulation; Virus Internalization | 2022 |
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine | 1992 |
Sertraline (Lustral) and paroxetine (Seroxat)--new drugs for the treatment of depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Humans; Paroxetine; Piperidines; Sertraline | 1991 |
[3H] sertraline binding to rat brain membranes.
Topics: 1-Naphthylamine; Animals; Brain; Fenclonine; Fluoxetine; Imipramine; In Vitro Techniques; Male; Membranes; Naphthalenes; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1990 |
The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain Chemistry; Eating; Fluoxetine; Fluvoxamine; Hydroxyindoleacetic Acid; Indoles; Male; Paroxetine; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1993 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Anxiety Disorders; Electric Injuries; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Substance Withdrawal Syndrome | 1995 |
Serotonin reuptake inhibitors in Raynaud's phenomenon.
Topics: 1-Naphthylamine; Adult; Aged; Cyclohexanols; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1995 |
Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.
Topics: 1-Naphthylamine; Blood Platelets; Calcium; Calmodulin; Cells, Cultured; Fluoxetine; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Anisocoria associated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Anisocoria; Antidepressive Agents; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Drug Interactions; Female; Humans; Lysergic Acid Diethylamide; Male; Paroxetine; Recurrence; Sertraline; Substance-Related Disorders; Syndrome | 1994 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid | 1994 |
Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55.
Topics: 1-Naphthylamine; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Cocaine; Fluoxetine; Hypothalamus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 1994 |
Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
Topics: 1-Naphthylamine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline | 1994 |
Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Clorgyline; Electrophysiology; Haloperidol; Male; N-Methylaspartate; Paroxetine; Pyramidal Cells; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sertraline; Tranylcypromine | 1993 |
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Libido; Middle Aged; Orgasm; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1995 |
Pharmacokinetics of the newer antidepressants.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Desipramine; Fluoxetine; Humans; Isoenzymes; Liver; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Drug-drug interactions.
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Mixed Function Oxygenases; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Ambulatory Care; Clozapine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical | 1996 |
Incentive bias?
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Costs; Drug Industry; Financial Support; Humans; Paroxetine; Prejudice; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Potential withdrawal syndrome associated with SSRI discontinuation.
Topics: 1-Naphthylamine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1995 |
In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2).
Topics: 1-Naphthylamine; Amoxicillin; Anti-Bacterial Agents; Antidepressive Agents; Cefotaxime; Corynebacterium; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Paroxetine; Risperidone; Serotonin Antagonists; Sertraline; Teicoplanin; Vancomycin | 1996 |
Withdrawal syndromes after paroxetine and sertraline discontinuation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1995 |
Sertraline and galactorrhea.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Female; Galactorrhea; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Serotonin reuptake inhibitor withdrawal.
Topics: 1-Naphthylamine; Adolescent; Adult; Age Factors; Clomipramine; Dizziness; Female; Fluvoxamine; Humans; Male; Middle Aged; Paresthesia; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Substance Withdrawal Syndrome | 1996 |
Reassessment of nefazodone.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles | 1996 |
Effect of valine on 5-HT neurotransmission and mood.
Topics: 1-Naphthylamine; Adult; Affect; Amino Acids, Branched-Chain; Amitriptyline; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fenfluramine; Humans; Lithium; Male; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Valine | 1996 |
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1996 |
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands].
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Belgium; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Effects of antidepressants on the cytochrome P450 system.
Topics: 1-Naphthylamine; Antidepressive Agents; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Medical Records; Paroxetine; Research Design; Sertraline | 1996 |
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1996 |
SSRI optimal dose remains at issue.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations.
Topics: 1-Naphthylamine; Antidepressive Agents; Drug Interactions; Fluoxetine; Humans; Paroxetine; Sertraline | 1997 |
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Female; Fluoxetine; Humans; Male; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires | 1997 |
The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychotic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval.
Topics: 1-Naphthylamine; Animals; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Membrane Potentials; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Tegmentum Mesencephali | 1997 |
Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Liver; Metabolic Clearance Rate; Mixed Function Oxygenases; Paroxetine; Psychotropic Drugs; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.
Topics: 1-Naphthylamine; Adverse Drug Reaction Reporting Systems; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; World Health Organization | 1997 |
Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Direct Service Costs; Drug Costs; Fee-for-Service Plans; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Models, Econometric; Multivariate Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Cohort Studies; Female; Fluvoxamine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior | 1997 |
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 1997 |
The SSRI antidepressants: exploring their "other" possible properties.
Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 1998 |
Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Antidepressive Agents; Female; Fluvoxamine; Humans; Paroxetine; Pregnancy; Pregnancy Outcome; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Blood Platelets; Carrier Proteins; Child; Depressive Disorder; Female; Humans; Kinetics; Male; Paroxetine; Serotonin; Sertraline | 1998 |
Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
Topics: 1-Naphthylamine; Citalopram; Drug Monitoring; Gas Chromatography-Mass Spectrometry; Humans; Paroxetine; Quality Control; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 1998 |
Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
Topics: Adrenergic beta-Antagonists; Animals; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Fluvoxamine; Male; Membrane Potentials; Neurons; Paroxetine; Propanolamines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Ventral Tegmental Area | 1998 |
Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.
Topics: Adult; Affective Symptoms; Aged; Brain Injuries; Cerebrovascular Disorders; Crying; Fluoxetine; Humans; Laughter; Male; Middle Aged; Multiple Sclerosis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Discontinuation of antidepressant therapy: emerging complications and their relevance.
Topics: Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Syndrome; Terminology as Topic | 1998 |
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline.
Topics: Animals; Biogenic Monoamines; Cerebral Cortex; Citalopram; Clozapine; Corpus Striatum; Diazepam; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; GABA Agents; Male; Norepinephrine; Nucleus Accumbens; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1999 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |
Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities.
Topics: Depressive Disorder; Drug Costs; Drug Prescriptions; Fluoxetine; Hospitals, Veterans; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.
Topics: Adult; Databases, Factual; Depressive Disorder; Drug Utilization; Episode of Care; Female; Fluoxetine; Humans; Logistic Models; Male; Multivariate Analysis; Paroxetine; Psychotherapy; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1999 |
Selective serotonin reuptake inhibitors and delusional depression.
Topics: Comorbidity; Delusions; Depressive Disorder; Humans; Paroxetine; Psychiatric Status Rating Scales; Psychometrics; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Excretion of paroxetine into breast milk.
Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides | 1999 |
[Severe withdrawal symptoms with fever upon stopping paroxetine].
Topics: Citalopram; Drug Administration Schedule; Fever; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1999 |
Serotonergic agents in the treatment of social phobia in children and adolescents: a case series.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Female; Humans; Male; Paroxetine; Phobic Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Triazoles | 1999 |
Modeling the pharmacoeconomic cost of three selective serotonin reuptake inhibitors.
Topics: Dose-Response Relationship, Drug; Fluoxetine; Follow-Up Studies; Humans; Mental Disorders; Mental Health Services; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Economic appraisal of citalopram in the management of single-episode depression.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Health Maintenance Organizations; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Retrospective Studies; Sertraline | 1999 |
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cost of Illness; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Care Costs; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1999 |
Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Carrier Proteins; Desipramine; Fluvoxamine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Paroxetine; Phenelzine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors | 1999 |
The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat.
Topics: Animals; Conditioning, Operant; Differential Threshold; Fluoxetine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Selective serotonin reuptake inhibitor-induced mydriasis.
Topics: Adolescent; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Mydriasis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2000 |
Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications.
Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluorometry; Fluoxetine; Fluvoxamine; Humans; Linear Models; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline | 2000 |
Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Autoreceptors; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Nortriptyline; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; RNA, Messenger; Sertraline | 2000 |
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles | 2000 |
Do antidepressants affect motivation in conditioned place preference?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclobutanes; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Motivation; Norepinephrine; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Serotonergic antidepressants and urinary incontinence.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride | 2000 |
Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors.
Topics: Aged; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Child, Preschool; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Humans; Hydroxylation; Male; Microsomes, Liver; Middle Aged; Paroxetine; Phenytoin; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 2001 |
Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
Topics: Adult; Antidepressive Agents; Cross-Sectional Studies; Drug Costs; Fluoxetine; Fluvoxamine; Forecasting; Humans; Insurance Claim Reporting; Insurance, Pharmaceutical Services; Middle Aged; Models, Theoretical; Ontario; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Prefrontal changes and treatment response prediction in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride | 2001 |
Economic evaluation of major selective serotonin-reuptake inhibitors in a managed care population.
Topics: Adolescent; Adult; Depressive Disorder; Drug Costs; Episode of Care; Fluoxetine; Humans; Managed Care Programs; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2001 |
Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Humans; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2001 |
[The transfer of selective serotonin reuptake inhibitors to human milk].
Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Milk, Human; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Use of sertraline, paroxetine and fluvoxamine by nursing women.
Topics: Breast Feeding; Chromatography, High Pressure Liquid; Depression, Postpartum; Female; Fluvoxamine; Humans; Infant, Newborn; Paroxetine; Regression Analysis; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Sertraline | 2001 |
The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization.
Topics: Adolescent; Adult; Cohort Studies; Cost Savings; Drug Costs; Emergency Service, Hospital; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Laboratories; Laboratories, Hospital; Male; Managed Care Programs; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare | 2001 |
[Critical ischaemia of the limbs and localized livedo in a case of ergotism].
Topics: Arm; Drug Interactions; Drug Therapy, Combination; Ergotamine; Ergotism; Female; Humans; Ischemia; Leg; Middle Aged; Migraine Disorders; Paroxetine; Sertraline; Skin Diseases, Vascular; Smoking; Ultrasonography, Doppler, Color | 2002 |
Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans.
Topics: Adolescent; Adult; Depressive Disorder; Drug Administration Schedule; Drug Costs; Female; Fluoxetine; Health Care Costs; Health Maintenance Organizations; Humans; Insurance, Pharmaceutical Services; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2002 |
Cross-sensitivity between paroxetine and sertraline.
Topics: Adult; Depression; Drug Eruptions; Exanthema; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Are paroxetine, fluoxetine, and sertraline equally effective for depression?
Topics: Adult; Depressive Disorder; Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
SSRIs: take your pick.
Topics: Depression; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents; Cells, Cultured; Chloride Channels; Citalopram; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluvoxamine; Humans; Hydrogen-Ion Concentration; Hypotonic Solutions; Inhibitory Concentration 50; Membrane Potentials; Paroxetine; Patch-Clamp Techniques; Pulmonary Artery; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cocaine; Conditioning, Psychological; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mesencephalon; Morphine; Motivation; Nucleus Accumbens; Paroxetine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Variations in antidepressant prescribing practice: clinical need or market influences?
Topics: Antidepressive Agents; Community Psychiatry; Drug Utilization Review; Fluoxetine; Humans; Marketing; Paroxetine; Physicians, Family; Practice Patterns, Physicians'; Sertraline; Surveys and Questionnaires | 2002 |
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration Schedule; Drug Costs; Drug Utilization; Fluoxetine; Fluvoxamine; Hospital Costs; Hospitals, Veterans; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2003 |
Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Utilization Review; Fluoxetine; Health Maintenance Organizations; Hospitalization; Humans; Medical Audit; Midwestern United States; Paroxetine; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Placental passage of antidepressant medications.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Maternal-Fetal Exchange; Paroxetine; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sertraline | 2003 |
Psychopharmacological treatment of major depressive disorder in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2003 |
Selective serotonin reuptake inhibitors in pilot fatalities of civil aviation accidents, 1990-2001.
Topics: Accidents, Aviation; Aerospace Medicine; Certification; Citalopram; Databases as Topic; Environmental Monitoring; Fluoxetine; Humans; Paroxetine; Postmortem Changes; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Rate; United States | 2003 |
Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors.
Topics: Aged; Aged, 80 and over; Depression; Diuretics; Female; Humans; Hydrochlorothiazide; Hypertension; Hyponatremia; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium Chloride Symporter Inhibitors | 2004 |
In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Hypogastric Plexus; In Vitro Techniques; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Seminal Vesicles; Serotonin; Sertraline; Vas Deferens | 2004 |
Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients.
Topics: Antidepressive Agents; Disorders of Excessive Somnolence; Electric Stimulation Therapy; Female; Humans; Lorazepam; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Parkinsonian Disorders; Paroxetine; Polysomnography; Preoperative Care; Prospective Studies; Sertraline; Sleep Stages; Subthalamic Nucleus; Surveys and Questionnaires; Videotape Recording | 2004 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Topics: Adult; Benzylamines; Carbon Radioisotopes; Carrier Proteins; Citalopram; Corpus Striatum; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2004 |
Successful treatment of trichotillomania with olanzapine augmentation in an adolescent.
Topics: Adolescent; Behavior Therapy; Benzodiazepines; Comorbidity; Drug Therapy, Combination; Female; Humans; Olanzapine; Paroxetine; Sertraline; Trichotillomania | 2004 |
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Dopamine beta-Hydroxylase; Droxidopa; Fluoxetine; Gene Deletion; Mice; Morpholines; Norepinephrine; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail | 2004 |
AUA guideline on the pharmacologic management of premature ejaculation.
Topics: Adult; Anesthetics, Local; Ejaculation; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Urology | 2004 |
Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.
Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Fatigue; Fluoxetine; Humans; Paroxetine; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Breast Feeding; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Depression, Postpartum; Female; Genotype; Humans; Infant; Infant, Newborn; Lactation; Male; Maternal Exposure; Milk, Human; Mixed Function Oxygenases; Paroxetine; Pharmacogenetics; Phenotype; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides | 2004 |
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
Topics: Animals; Citalopram; Cladocera; Ecosystem; Female; Fluoxetine; Fluvoxamine; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Paroxetine; Reproduction; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical | 2004 |
In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
Topics: Analysis of Variance; Animals; Area Under Curve; Binding Sites; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Paroxetine; Radioligand Assay; Receptors, Serotonin; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Tritium | 2004 |
Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Child; Drug Approval; Fluoxetine; France; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2004 |
Binding of S-citalopram and paroxetine discriminates between species.
Topics: Animals; Benzylamines; Binding, Competitive; Brain; Cells, Cultured; Chickens; Citalopram; Evolution, Molecular; Humans; Isoquinolines; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Species Specificity; Tritium | 2005 |
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
Topics: Animals; Behavior, Animal; Binding Sites; Brain; Fluoxetine; Fluvoxamine; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Motor Activity; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2005 |
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Anxiety Disorders; Citalopram; Cohort Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2005 |
Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine.
Topics: Chemistry, Pharmaceutical; Fenfluramine; Magnetic Resonance Spectroscopy; Molecular Structure; Paroxetine; Protons; Reference Standards; Sertraline; Stereoisomerism | 2005 |
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice.
Topics: Animals; Anti-Dyskinesia Agents; Catalepsy; Disease Models, Animal; Female; Fluoxetine; Haloperidol; Male; Mice; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Time Factors | 2005 |
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.
Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical | 2006 |
I have read about a new study that showed antidepressants can increase the risk of abdominal bleeding. I'm currently taking Prozac, and my husband takes Zoloft. Should we worry?
Topics: Antidepressive Agents; Drug Interactions; Female; Fluoxetine; Gastrointestinal Hemorrhage; Humans; Male; Paroxetine; Polypharmacy; Sertraline | 2006 |
The characterisation of selected antidepressant drugs using electrospray ionisation with ion trap mass spectrometry and with quadrupole time-of-flight mass spectrometry and their determination by high-performance liquid chromatography/electrospray ionisat
Topics: Antidepressive Agents; Calibration; Chromatography, High Pressure Liquid; Hair; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry | 2006 |
Antidepressant therapy and C-reactive protein levels.
Topics: Adult; Aged; C-Reactive Protein; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.
Topics: Adolescent; Adult; Anxiety Disorders; Citalopram; Cohort Studies; Cost Sharing; Databases, Factual; Depression; Drug Prescriptions; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2006 |
Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Citalopram; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2006 |
Disappointment of patients on antidepressant therapy after excimer laser treatment.
Topics: Adult; Alprazolam; Antidepressive Agents; Dry Eye Syndromes; Female; Humans; Keratomileusis, Laser In Situ; Middle Aged; Mydriasis; Myopia; Paroxetine; Patient Satisfaction; Patients; Sertraline; Vision Disorders | 2006 |
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Chemistry; Carrageenan; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Duloxetine Hydrochloride; Edema; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Paroxetine; Pressure; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Venlafaxine Hydrochloride | 2006 |
Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.
Topics: Adolescent; Adult; Aged; Catchment Area, Health; Citalopram; Cost-Benefit Analysis; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Health Expenditures; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Spain | 2006 |
The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
Topics: Cross-Sectional Studies; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Medication Errors; Middle Aged; Paroxetine; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Veterans | 2007 |
Antidepressant response in the elderly.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression.
Topics: Anti-Inflammatory Agents; Antidepressive Agents; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cytokines; Dexamethasone; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Oligonucleotide Array Sequence Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; STAT3 Transcription Factor; T-Lymphocytes | 2007 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome | 2008 |
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.
Topics: Animals; Cell Line, Tumor; Diabetes Mellitus; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Metabolic Syndrome; Paroxetine; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Selective Serotonin Reuptake Inhibitors; Serine; Sertraline; Signal Transduction | 2007 |
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Motor Activity; Paroxetine; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Swimming | 2008 |
Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
Topics: Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Citalopram; Cost-Benefit Analysis; Depression; Drugs, Generic; Female; Fluoxetine; Humans; Male; Medicare; Models, Statistical; Paroxetine; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A comparison of antidepressant use in Nova Scotia, Canada and Australia.
Topics: Aged; Antidepressive Agents; Australia; Canada; Databases, Factual; Depressive Disorder, Major; Female; Humans; Male; Nova Scotia; Paroxetine; Practice Patterns, Physicians'; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline | 2008 |
Clinical inquiries. What's the best drug treatment for premature ejaculation?
Topics: Anesthetics, Local; Antidepressive Agents; Clomipramine; Ejaculation; Fluoxetine; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Paroxetine; Phosphodiesterase Inhibitors; Prilocaine; Sertraline; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders.
Topics: Animals; Antidepressive Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Clomipramine; Cyclooxygenase 2; Female; Immune System Diseases; Lymphocyte Activation; Lymphocytes; Mitogen-Activated Protein Kinases; Paroxetine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred Lew; Sertraline; Spleen; Tumor Necrosis Factor-alpha | 2008 |
[Psychopharmacological treatment and quality of life in obsessive compulsive disorder].
Topics: Adult; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat.
Topics: Animals; Brain; Brain Mapping; Carbon Isotopes; Deoxyglucose; Dose-Response Relationship, Drug; Fluoxetine; Male; Paroxetine; Radionuclide Imaging; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Sertraline; Wakefulness | 2008 |
Block of persistent late Na+ currents by antidepressant sertraline and paroxetine.
Topics: Amino Acid Substitution; Anesthetics, Local; Animals; Antidepressive Agents; Binding Sites; Cell Line; Humans; Kinetics; Muscle Proteins; Mutagenesis, Site-Directed; NAV1.7 Voltage-Gated Sodium Channel; Paroxetine; Phenylalanine; Rats; Recombinant Proteins; Sertraline; Sodium Channel Blockers; Sodium Channels | 2008 |
Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.
Topics: Animals; Citalopram; Male; Mice; Models, Biological; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 2008 |
Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice.
Topics: Adenocarcinoma; Animals; Antidepressive Agents; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Paroxetine; Sertraline; Xenograft Model Antitumor Assays | 2008 |
Flat dose-response curves for efficacy: what do they mean to the clinician?
Topics: Attitude of Health Personnel; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Physicians; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; United States; United States Food and Drug Administration | 2008 |
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis | 2008 |
[Sleep spindles in post traumatic stress disorder: significant importance of selective serotonin reuptake inhibitors].
Topics: Citalopram; Electromyography; Electrooculography; Humans; Paroxetine; Reference Values; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep, REM; Stress Disorders, Post-Traumatic; Wakefulness | 2008 |
An imperfect literature and evidence-based medicine.
Topics: Abnormalities, Drug-Induced; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression, Postpartum; Evidence-Based Medicine; Female; Humans; Nortriptyline; Paroxetine; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior | 2009 |
Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis.
Topics: Antidepressive Agents; Citalopram; Drug Monitoring; Electrophoresis, Capillary; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.
Topics: Adult; Aged; Antidepressive Agents; Biomarkers; Citalopram; Depression; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2009 |
Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Chemotherapy, Adjuvant; Doxorubicin; Drug Interactions; Humans; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Mitogen-Activated Protein Kinases; Paroxetine; Proto-Oncogene Mas; Selective Serotonin Reuptake Inhibitors; Sertraline; Vincristine | 2009 |
Paroxetine inhibited the relaxations induced by EFS in mice corpus cavernosum: is it a NOS inhibition?
Topics: Animals; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Male; Mice; Mice, Inbred BALB C; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Paroxetine; Penis; Phenylephrine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Effects of paroxetine and sertraline on low-density lipoprotein cholesterol: an observational cohort study.
Topics: Adult; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Risk Factors; Sertraline; Time Factors | 2009 |
Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.
Topics: Adult; Alleles; Female; Genotype; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
Topics: Asian People; Depressive Disorder, Major; Fluvoxamine; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Paroxetine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.
Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineralocorticoid Receptor Antagonists; Models, Economic; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.
Topics: Animals; Corpus Striatum; Dopamine; Extracellular Space; Fluvoxamine; Male; Microdialysis; Norepinephrine; Nucleus Accumbens; Paroxetine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 2010 |
The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.
Topics: Adult; Aged; Asian People; Biomarkers; Brain-Derived Neurotrophic Factor; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Heterozygote; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2011 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2011 |
Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.
Topics: Adult; Asian People; Case-Control Studies; Circadian Clocks; Depressive Disorder, Major; Endopeptidases; Female; Fluvoxamine; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Paroxetine; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Ubiquitin | 2011 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
Cost-effectiveness analysis of burning mouth syndrome therapy.
Topics: Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Cost-Benefit Analysis; Decision Trees; Dental Care; Drug Costs; Health Care Costs; Humans; Paroxetine; Sertraline; Sulpiride | 2012 |
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochondriasis; Hysteria; Male; Middle Aged; MMPI; Neurotic Disorders; Observer Variation; Paroxetine; Psychometrics; Reproducibility of Results; Sertraline; Statistics as Topic; Young Adult | 2011 |
Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.
Topics: Animals; Antidepressive Agents; Coumaric Acids; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Immobility Response, Tonic; Ketanserin; Male; Mice; Motor Activity; Paroxetine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Sertraline | 2012 |
High venlafaxine serum levels after prior fluoxetine medication.
Topics: Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
Comparison of two extraction methods for the determination of selective serotonin reuptake inhibitors in sewage sludge by hollow fiber liquid-phase microextraction.
Topics: Chromatography, Liquid; Citalopram; Fluoxetine; Liquid Phase Microextraction; Mass Spectrometry; Paroxetine; Porosity; Selective Serotonin Reuptake Inhibitors; Sertraline; Sewage; Surface Properties | 2012 |
Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
Topics: Animals; Apoptosis; Cell Death; Cell Line; Diabetes Mellitus; Fluoxetine; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Unfolded Protein Response | 2013 |
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; Databases, Factual; Fluoxetine; Fluvoxamine; Humans; Infant; Mental Disorders; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Bulgaria; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Republic of North Macedonia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials.
Topics: Acoustic Stimulation; Adult; Brain; Citalopram; Cross-Sectional Studies; Depressive Disorder, Major; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Hypnotics and Sedatives; Loudness Perception; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Dysfunction, Physiological | 2014 |
Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Enlargement; Cells, Cultured; Citalopram; Dendrites; Fluoxetine; Hippocampus; Imipramine; Nerve Tissue Proteins; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Sertraline; Thiazepines; Tranylcypromine | 2014 |
Editorial Comment from Dr Sato to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Editorial Comment from Dr Amano to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Response to Editorial Comments to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Suicide attempt and externalizing behaviours in posttraumatic stress disorder (PTSD): possible role of the activating effect of antidepressants.
Topics: Adult; Female; Humans; Mental Disorders; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Suicide, Attempted | 2015 |
Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity.
Topics: Animals; Antidepressive Agents; Arterial Pressure; Baroreflex; Cardiovascular Physiological Phenomena; Fluoxetine; Heart Rate; Kidney; Male; Paroxetine; Rats, Wistar; Respiratory Rate; Selective Serotonin Reuptake Inhibitors; Sertraline; Sympathetic Nervous System; Vital Signs | 2014 |
Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
Topics: Adult; Citalopram; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Child; Citalopram; Databases, Factual; Drug Monitoring; Drug Utilization; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2015 |
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Topics: Adult; Asia, Eastern; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Pain; Paroxetine; Prospective Studies; Quality of Life; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2016 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Citalopram; Estradiol; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Progesterone; Selective Serotonin Reuptake Inhibitors; Sertraline; Testosterone | 2015 |
Topiramate augmentation in a patient with obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Humans; Lorazepam; Obsessive-Compulsive Disorder; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate; Treatment Refusal | 2015 |
Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Citalopram; Cyclopropanes; Duloxetine Hydrochloride; Fluvoxamine; Hep G2 Cells; Humans; Liver Neoplasms; Milnacipran; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline | 2015 |
Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
Topics: Adolescent; Adult; Antidepressive Agents; Child; Child, Preschool; Citalopram; Cohort Studies; Databases, Factual; Depression; Dose-Response Relationship, Drug; Drug Labeling; Drug Prescriptions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Suicide, Attempted; United States; United States Food and Drug Administration; Young Adult | 2016 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
Time-course of serotonin transporter occupancy by single dose of three SSRIs in human brain: A positron emission tomography study with [(11)C]DASB.
Topics: Adult; Benzylamines; Brain; Carbon Radioisotopes; Citalopram; Dose-Response Relationship, Drug; Female; Humans; Male; Paroxetine; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Young Adult | 2016 |
Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
Topics: Adult; Aged; Brazil; Citalopram; Electrocardiography; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors.
Topics: Adult; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2016 |
Are sertraline, paroxetine and duloxetine the most effective antidepressants for use in depressed adults over 60 years?
Topics: Adult; Antidepressive Agents; Duloxetine Hydrochloride; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Short-Term Safety of Paroxetine and Sertraline in Breastfed Infants: A Retrospective Cohort Study from a University Hospital.
Topics: Breast Feeding; Depression, Postpartum; Female; Hospitals, University; Humans; Infant; Infant, Newborn; Milk, Human; Mothers; Paroxetine; Practice Guidelines as Topic; Pregnancy; Retrospective Studies; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Exposure to SSRI-type antidepressants increases righting time in the marine snail Ilyanassa obsoleta.
Topics: Animals; Antidepressive Agents; Fluoxetine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Snails; Venlafaxine Hydrochloride | 2017 |
Selective serotonin reuptake inhibitor sertraline inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.
Topics: Animals; Coronary Vessels; Dose-Response Relationship, Drug; Myocytes, Smooth Muscle; Paroxetine; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Rabbits; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 2016 |
In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates.
Topics: Animals; Antifungal Agents; Apoptosis; Biofilms; Candida; Cell Count; Cell Death; Cell Line; Cell Proliferation; DNA Damage; DNA, Fungal; Drug Resistance, Fungal; Fibroblasts; Flow Cytometry; Fluconazole; In Vitro Techniques; Membrane Potentials; Mice; Microbial Sensitivity Tests; Microbial Viability; Mitochondrial Membranes; Paroxetine; Plasma; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
A comparative study of QT prolongation with serotonin reuptake inhibitors.
Topics: Adult; Aged; Arrhythmias, Cardiac; Citalopram; Databases, Factual; Female; Fluvoxamine; Humans; Long QT Syndrome; Male; Middle Aged; Paroxetine; Pharmacovigilance; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Impact of selective serotonin reuptake inhibitors on neural crest stem cell formation.
Topics: Antidepressive Agents; Cell Line; Cell Movement; Cell Proliferation; Embryonic Stem Cells; Gene Expression Regulation; Humans; Neural Crest; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Transcription Factor AP-2 | 2017 |
[Exploring the clinical characters of Shugan Jieyu capsule through text mining].
Topics: Anxiety; Data Mining; Depression; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluoxetine; Humans; Paroxetine; Sertraline | 2017 |
Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing.
Topics: Ancylostoma; Animals; Anthelmintics; Caenorhabditis elegans; Chlorpromazine; Drug Discovery; Drug Repositioning; Drug Resistance; Paroxetine; Schistosoma mansoni; Sertraline | 2018 |
Structural basis for recognition of diverse antidepressants by the human serotonin transporter.
Topics: Antidepressive Agents; Binding Sites; Chemistry, Pharmaceutical; Crystallography, X-Ray; Fluvoxamine; Humans; Kinetics; Mutation; Paroxetine; Protein Binding; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2018 |
Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Topics: Altitude Sickness; Animals; Antidepressive Agents; Brain; Citalopram; Dopamine; Female; Fluoxetine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Citalopram; Epithelial Cells; Fluoxetine; Paroxetine; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Sertraline; Swine | 2018 |
A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.
Topics: Adult; Anticonvulsants; Female; Fluoxetine; Humans; Male; Medical Records; Middle Aged; Outpatients; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; Treatment Outcome; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2018 |
A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression.
Topics: Adult; Aged; Aged, 80 and over; Animals; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Receptors, Serotonin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2020 |
Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence.
Topics: Citalopram; Databases, Factual; Drugs, Generic; Humans; Paroxetine; Practice Patterns, Physicians'; Prescription Fees; Scotland; Selective Serotonin Reuptake Inhibitors; Sertraline; State Medicine | 2019 |
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2019 |
Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs.
Topics: Amitriptyline; Chromatography, Liquid; Drug Storage; Fentanyl; Flunitrazepam; Fluoxetine; Humans; Mass Spectrometry; Nortriptyline; Paroxetine; Point-of-Care Testing; Sertraline | 2019 |
Serotonin and serotonin reuptake inhibitors alter placental aromatase.
Topics: Aromatase; Cells, Cultured; Citalopram; Female; Fluoxetine; Humans; Molecular Docking Simulation; Paroxetine; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Trophoblasts; Venlafaxine Hydrochloride | 2019 |
The teratogenic effects of sertraline in mice.
Topics: Animals; Citalopram; Female; Humans; Mice; Mice, Inbred ICR; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2020 |
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Topics: Aged; Antidepressive Agents; Depression; Female; Fractures, Bone; Humans; Male; North America; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Taiwan; United Kingdom; Venlafaxine Hydrochloride | 2020 |
Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014).
Topics: Adolescent; Adult; Cohort Studies; Female; Humans; Middle Aged; Paroxetine; Pregnancy; Pregnancy Trimesters; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2021 |
Evidence-based prescribing for post-traumatic stress disorder.
Topics: Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2020 |
Comparing Medications for DSM-5 PTSD in Routine VA Practice.
Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Female; Fluoxetine; Humans; Male; Medication Adherence; Outcome Assessment, Health Care; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2020 |
Low SSRI dosing in clinical practice-a register-based longitudinal study.
Topics: Child; Citalopram; Fluoxetine; Humans; Longitudinal Studies; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
[Hair Loss Associated with Paroxetine Use: A Case Report].
Topics: Adult; Alopecia; Antidepressive Agents; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2021 |
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.
Topics: Antidepressive Agents; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P450 Family 2; Drug Interactions; Humans; Paroxetine; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
Topics: Androgens; Animals; Carbamazepine; Central Nervous System Agents; CHO Cells; Clonazepam; Cricetinae; Cricetulus; Estrogen Receptor alpha; Estrogens; Fluoxetine; Glucocorticoids; Luciferases, Firefly; Paroxetine; Receptors, Androgen; Receptors, Glucocorticoid; Sertraline; Thyroid Gland | 2022 |
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2022 |
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2022 |
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2022 |
Chronic multiple mild stress induces sustained adverse psychological states in rats.
Topics: Adrenocorticotropic Hormone; Animals; Brain-Derived Neurotrophic Factor; Glucocorticoids; Humans; Paroxetine; Rats; Serotonin; Sertraline; Stress, Psychological | 2022 |
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Fluoxetine; Mice; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2023 |
Estimating the prevalence of depression using wastewater-based epidemiology: A case study in Qinghai Province, West China.
Topics: Antidepressive Agents; China; Depression; Paroxetine; Prevalence; Sertraline; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical | 2023 |